Selective deletion of long but not short cypher isoforms leads to late-onset dilated cardiomyopathy

Human Molecular Genetics

Volumn 20, Issue 9, 2011, Pages 1751-1762

  Cheng, Hongqiang ^a   Zheng, Ming ^a,b   Peter, Angela K ^a   Kimura, Kensuke ^a   Li, Xiaodong ^a   Ouyang, Kunfu ^a   Shen, Tao ^a   Cui, Li ^a   Frank, Derk ^c   Dalton, Nancy D ^a   Gu, Yusu ^a   Frey, Norbert ^c   Peterson, Kirk L ^a   Evans, Sylvia M ^a   Knowlton, Kirk U ^a   Sheikh, Farah ^a   Chen, Ju ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b PEKING UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; ISOPROTEIN; LIM PROTEIN; PDZ PROTEIN; PROTEIN CYPHER; PROTEIN KINASE C; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIFICATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; GROWTH RETARDATION; HEART DILATATION; HEART MUSCLE FIBROSIS; HYPOTHESIS; LETHALITY; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; ULTRASTRUCTURE;

ANIMALS; CARDIOMYOPATHY, DILATED; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, STRIATED; PROTEIN ISOFORMS;

MUS;

EID: 79954480914     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr050     Document Type: Article

References (49)

1. Zhou, Q., Ruiz-Lozano, P., Martone, M.E. and Chen, J. (1999) Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C. J. Biol. Chem., 274, 19807-19813.
2. Velthuis, A.J.W.T. and Bagowski, C.P. (2007) PDZ and LIM domain-encoding genes: molecular interactions and their role in development. Scientific World Journal, 7, 1470-1492.
3. Zheng, M., Cheng, H., Banerjee, I. and Chen, J. (2010) ALP/Enigma PDZ-LIM domain proteins in the heart. J. Mol. Cell Biol., 2, 96-102.
4. Faulkner, G., Pallavicini, A., Formentin, E., Comelli, A., Ievolella, C., Trevisan, S., Bortoletto, G., Scannapieco, P., Salamon, M., Mouly, V. et al. (1999) ZASP: a new Z-band alternatively spliced PDZ-motif protein. J. Cell Biol., 146, 465-475.
5. Passier, R., Richardson, J.A. and Olson, E.N. (2000) Oracle, a novel PDZ-LIM domain protein expressed in heart and skeletal muscle. Mech. Dev., 92, 277-284.
6. van der Meer, D.L.M., Marques, I.J., Leito, J.T.D., Besser, J., Bakkers, J., Schoonheere, E. and Bagowski, C.P. (2006) Zebrafish cypher is important for somite formation and heart development. Dev. Biol., 299, 356-372.
7. Sheikh, F., Bang, M.L., Lange, S. and Chen, J. (2007) "Z7) "eroing in on the role of Cypher in striated muscle function, signaling, and human disease. Trends Cardiovasc. Med., 17, 258-262.
8. Jani, K. and Schock, F. (2007) ZASP is required for the assembly of functional integrin adhesion sites. J. Cell Biol., 179, 1583-1597.
9. Benna, C., Peron, S., Rizzo, G., Faulkner, G., Megighian, A., Perini, G., Tognon, G., Valle, G., Reggiani, C., Costa, R. et al. (2009) Post-transcriptional silencing of the Drosophila homolog of human ZASP: a molecular and functional analysis. Cell Tissue Res., 337, 463-476.
10. Zhou, Q., Chu, P.H., Huang, C., Cheng, C.F., Martone, M.E., Knoll, G., Shelton, G.D., Evans, S. and Chen, J. (2001) Ablation of Cypher, a PDZ- LIM domain Z-line protein, causes a severe form of congenital myopathy. J. Cell Biol., 155, 605-612.
11. Zheng, M., Cheng, H., Li, X., Zhang, J., Cui, L., Ouyang, K., Han, L., Zhao, T., Gu, Y., Dalton, N.D. et al. (2009) Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. Hum. Mol. Genet., 18, 701-713.
12. Arimura, T., Hayashi, T., Terada, H., Lee, S.Y., Zhou, Q., Takahashi, M., Ueda, K., Nouchi, T., Hohda, S., Shibutani, M. et al. (2004) A Cypher/ ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C. J. Biol. Chem., 279, 6746-6752.
13. Vatta, M., Mohapatra, B., Jimenez, S., Sanchez, X., Faulkner, G., Perles, Z., Sinagra, G., Lin, J.H., Vu, T.M., Zhou, Q. et al. (2003) Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J. Am. Coll. Cardiol., 42, 2014-2027.
14. Selcen, D. and Carpen, O. (2008) The Z-disk diseases. Adv. Exp. Med. Biol., 642, 116-130.
15. Ichida, F. (2009) Left ventricular noncompaction. Circ. J., 73, 19-26.
16. Ferrer, I. and Olive, M. (2008) Molecular pathology of myofibrillar myopathies. Expert Rev. Mol. Med., 10, e25.
17. Moric-Janiszewska, E. and Markiewicz-Loskot, G. (2008) Genetic heterogeneity of left-ventricular noncompaction cardiomyopathy. Clin. Cardiol., 31, 201-204.
18. Selcen, D. and Engel, A.G. (2005) Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann. Neurol., 57, 269-276.
19. Griggs, R., Vihola, A., Hackman, P., Talvinen, K., Haravuori, H., Faulkner, G., Eymard, B., Richard, I., Selcen, D., Engel, A. et al. (2007) Zaspopathy in a large classic late-onset distal myopathy family. Brain, 130, 1477-1484.
20. Arimura, T., Inagaki, N., Hayashi, T., Shichi, D., Sato, A., Hinohara, K., Vatta, M., Towbin, J.A., Chikamori, T., Yamashina, A. et al. (2009) Impaired binding of ZASP/Cypher with phosphoglucomutase 1 is associated with dilated cardiomyopathy. Cardiovasc. Res., 83, 80-88.
21. Huang, C.Q., Zhou, Q., Liang, P.H., Hollander, M.S., Sheikh, F., Li, X.D., Greaser, M., Shelton, G.D., Evans, S. and Chen, J. (2003) Characterization and in vivo functional analysis of splice variants of cypher. J. Biol. Chem., 278, 7360-7365.
22. Cheng, H., Kimura, K., Peter, A.K., Cui, L., Ouyang, K., Shen, T., Liu, Y., Gu, Y., Dalton, N.D., Evans, S.M. et al. (2010) Loss of enigma homolog protein results in dilated cardiomyopathy. Circ. Res., 107, 348-356.
23. Marziliano, N., Mannarino, S., Nespoli, L., Diegoli, M., Pasotti, M., Malattia, C., Grasso, M., Pilotto, A., Porcu, E., Raisaro, A. et al. (2007) Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am. J. Med. Genet. A, 143A, 907-915.
24. Theis, J.L., Bos, J.M., Bartleson, V.B., Will, M.L., Binder, J., Vatta, M., Towbin, J.A., Gersh, B.J., Ommen, S.R. and Ackerman, M.J. (2006) Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun., 351, 896-902.
25. von Nandelstadh, P., Ismail, M., Gardin, C., Suila, H., Zara, I., Belgrano, A., Valle, G., Carpen, O. and Faulkner, G. (2009) A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies. Mol. Cell. Biol., 29, 822-834.
26. Klaavuniemi, T. and Ylanne, J. (2006) Zasp/Cypher internal ZM-motif containing fragments are sufficient to co-localize with alpha-actinin: analysis of patient mutations. Exp. Cell Res., 312, 1299-1311.
27. Sanna, B., Brandt, E.B., Kaiser, R.A., Pfluger, P., Witt, S.A., Kimball, T.R., van Rooij, E., De Windt, L.J., Rothenberg, M.E., Tschop, M.H. et al. (2006) Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo. Proc. Natl Acad. Sci. USA, 103, 7327-7332.
28. Molkentin, J.D. (2004) Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc. Res., 63, 467-475.
29. Frey, N., Barrientos, T., Shelton, J.M., Frank, D., Rutten, H., Gehring, D., Kuhn, C., Lutz, M., Rothermel, B., Bassel-Duby, R. et al. (2004) Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med., 10, 1336-1343.
30. Frey, N., Richardson, J.A. and Olson, E.N. (2000) Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl Acad. Sci. USA, 97, 14632-14637.
31. Frank, D., Kuhn, C., van Eickels, M., Gehring, D., Hanselmann, C., Lippl, S., Will, R., Katus, H.A. and Frey, N. (2007) Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy. Circulation, 116, 2587-2596.
32. Molkentin, J.D. (2000) Calcineurin and beyond: cardiac hypertrophic signaling. Circ. Res., 87, 731-738.
33. Molkentin, J.D., Lu, J.R., Antos, C.L., Markham, B., Richardson, J., Robbins, J., Grant, S.R. and Olson, E.N. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 93, 215-228.
34. Wilkins, B.J., Dai, Y.S., Bueno, O.F., Parsons, S.A., Xu, J., Plank, D.M., Jones, F., Kimball, T.R. and Molkentin, J.D. (2004) Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res., 94, 110-118.
35. Rothermel, B.A., Vega, R.B. and Williams, R.S. (2003) The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc. Med., 13, 15-21.
36. Dorn, G.W. II and Force, T. (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest., 115, 527-537.
37. Palaniyandi, S.S., Sun, L., Ferreira, J.C. and Mochly-Rosen, D. (2009) Protein kinase C in heart failure: a therapeutic target? Cardiovasc. Res., 82, 229-239.
38. Churchill, E., Budas, G., Vallentin, A., Koyanagi, T. and Mochly-Rosen, D. (2008) PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu. Rev. Pharmacol. Toxicol., 48, 569-599.
39. Braun, M.U., LaRosee, P., Schon, S., Borst, M.M. and Strasser, R.H. (2002) Differential regulation of cardiac protein kinase C isozyme expression after aortic banding in rat. Cardiovasc. Res., 56, 52-63.
40. Bowling, N., Walsh, R.A., Song, G., Estridge, T., Sandusky, G.E., Fouts, R.L., Mintze, K., Pickard, T., Roden, R., Bristow, M.R. et al. (1999) Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation, 99, 384-391.
41. Simpson, P.C. (1999) Beta-protein kinase C and hypertrophic signaling in human heart failure. Circulation, 99, 334-337.
42. Wakasaki, H., Koya, D., Schoen, F.J., Jirousek, M.R., Ways, D.K., Hoit, B.D., Walsh, R.A. and King, G.L. (1997) Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc. Natl Acad. Sci. USA, 94, 9320-9325.
43. Goldspink, P.H., Montgomery, D.E., Walker, L.A., Urboniene, D., McKinney, R.D.,Geenen,D.L., Solaro, R.J. andButtrick,P.M.(2004)Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ. Res., 95,424-432.
44. Takeishi, Y., Ping, P., Bolli, R., Kirkpatrick, D.L., Hoit, B.D. and Walsh, R.A. (2000) Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ. Res., 86, 1218-1223.
45. Liang, X., Zhou, Q., Li, X., Sun, Y., Lu, M., Dalton, N., Ross, J. Jr. and Chen, J. (2005) PINCH1 plays an essential role in early murine embryonic development but is dispensable in ventricular cardiomyocytes. Mol. Cell. Biol., 25, 3056-3062.
46. Rodriguez, C.I., Buchholz, F., Galloway, J., Sequerra, R., Kasper, J., Ayala, R., Stewart, A.F. and Dymecki, S.M. (2000) High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet., 25, 139-140.
47. O'Gorman, S., Dagenais, N.A., Qian, M. and Marchuk, Y. (1997) Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl Acad. Sci. USA, 94, 14602-14607.
48. Rungby, J., Kassem, M., Eriksen, E.F. and Danscher, G. (1993) The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background. Histochem. J., 25, 446-451.
49. Chang, S., McKinsey, T.A., Zhang, C.L., Richardson, J.A., Hill, J.A. and Olson, E.N. (2004) Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol., 24, 8467-8476.